@article{d5cb22f3ca154b0aac5d92298b7a6043,
title = "After Avandia: The Use of Antidiabetic Drugs in Patients with Heart Failure",
author = "Khalaf, \{Khaled I.\} and Heinrich Taegtmeyer",
note = "Managing diabetes mellitus is an ongoing concern, especially in the presence of heart failure. Recent reports have drawn attention to adverse cardiovascular events associated with the use of thiazolidinediones, including rosiglitazone (Avandia). In 2011, the U.S. Food and Drug Administration implemented a stringent {"}restricted access program{"} for the prescription of Avandia.",
year = "2012",
month = jan,
day = "1",
language = "American English",
volume = "39",
journal = "Texas Heart Institute Journal",
number = "2",
}